Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 16 Mar 2023
Avascular necrosis (AVN) is considered an iatrogenic complication after treatment for progressive hip dysplasia, but research in China has revealed two characteristics associated with this condition. ossification nuclei.
Read Full NewsHow a cardiac procedure exposed the tension between a mother’s autonomy and her son’s medical expertise.
A young woman grieving a miscarriage was labeled "hysteria." Dr Loshi Rajen reflects on diagnostic bias, the enduring power of psychiatric labels, and the importance of recognizing normal grief.
Doctors are no longer the only source of medical knowledge in the room, and the future may depend on who preserves the most humanity.
Emerging research suggests vulnerability to substance use disorders may begin before the first drink or drug. Drs Leslie A. Hulvershorn and Paola P. Mattey Mora explain why.
Symptomatic relief from nerve stimulation treatment may persist after stopping the treatment in most children with overactive bladder.
Unsweetened dairy may help protect enamel, but added sugar can erase the benefit. Breastfeeding and milk alternatives also have surprising age- and product-specific effects.
In primary care settings, recognizing the difference between seborrheic keratosis and melanoma can guide timely biopsy and reduce missed diagnoses.
1.
High Rate of Deep Remission for Relapsed/Refractory CLL Using Triple Regimen.
2.
Outcomes in Resected Melanoma Influenced by Timing of Recurrence
3.
For incarcerated people, study shows gaps exist in quality of cancer care
4.
Promising for Monitoring and Diagnosis of AD is the finger-prick test.
5.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
1.
The Future of Hemophilia Treatment: Long-Acting Therapies and Gene Editing
2.
Protein S-Palmitoylation in Cancer: A Novel Target in Immunotherapy & Treatment
3.
Cancer-Keeper Genes: Novel Therapeutic Targets for Disrupting Tumor Maintenance
4.
Vaso Occlusive Crisis: Understanding the Painful Reality of Sickle Cell Disease
5.
Machine Learning in Hematology: Boosting Diagnostic Precision and Speed in Medical Practice
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
2.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
3.
Navigating the Complexities of Ph Negative ALL - Part III
4.
Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion
5.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge